This segment focuses on providing instruments, consumables, and software for single-cell analysis. 10x Genomics' single-cell solutions, running on Chromium instruments, enable researchers to measure gene expression on a cell-by-cell basis, profile immune cells, and analyze epigenetics. The technologies used include microfluidic chips, reagents, and specialized software for data analysis. This segment supports research in various therapeutic areas, including oncology, immunology, and rare diseases, by providing tools to understand cellular heterogeneity and identify potential drug targets. The impact is improved understanding of disease mechanisms and the development of more effective therapies. 10x Genomics holds a strong market position due to its innovative technology and comprehensive solutions. Future opportunities include expanding the applications of single-cell analysis in clinical diagnostics and drug discovery. Regulatory aspects involve compliance with FDA and other regulatory bodies for diagnostic applications. Partnerships with research institutions and biopharmaceutical companies are crucial for driving innovation and market adoption.

This segment offers Visium spatial gene expression solutions, enabling researchers to measure gene expression patterns across tissue samples. The technology allows for gene expression and protein co-detection when combined with immunofluorescence. Research and development activities focus on improving the resolution and throughput of spatial analysis. The technologies used include specialized slides, reagents, and software for data analysis. This segment supports research in oncology, neurology, and other areas by providing tools to understand the spatial organization of cells and their interactions within tissues. The impact is improved understanding of disease progression and the identification of new therapeutic targets. 10x Genomics' market position is strong due to its innovative spatial biology platform. Future opportunities include expanding the applications of spatial analysis in drug discovery and diagnostics. Regulatory aspects involve compliance with FDA and other regulatory bodies for diagnostic applications. Partnerships with research institutions and biopharmaceutical companies are crucial for driving innovation and market adoption.